Veracyte
VCYT
80 hedge funds and large institutions have $137M invested in Veracyte in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 8 closing their positions.
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
1% more funds holding
Funds holding: 79 → 80 (+1)
0.87% more ownership
Funds ownership: 70.99% → 71.86% (+0.87%)
13% less capital invested
Capital invested by funds: $158M → $137M (-$20.8M)
21% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 28
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
97% less call options, than puts
Call options by funds: $17K | Put options by funds: $638K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$8.72M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$918K |
| 3 |
CC
Cannell Capital
Alta,
Wyoming
|
+$907K |
| 4 |
JP Morgan Chase
New York
|
+$768K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$573K |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$3.92M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.85M |
| 3 |
BC
Broadfin Capital
New York
|
-$902K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$454K |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$424K |
VCYT Hedge Fund Activity: Q1 2018 in Review
80 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2018, worth a combined $137M — down 13% from $158M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VCYT positions and 8 closed out — a net gain of 1 holder — while 22 added to existing stakes and 28 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $8.72M. The largest seller was Avoro Capital Advisors, cutting an estimated $3.92M.
- 80 institutional investors held Veracyte (VCYT) as of Q1 2018, up from 79 in Q4 2017.
- Funds reported $137M of Veracyte stock for Q1 2018, down 13% quarter-over-quarter.
- 9 funds opened new Veracyte positions in Q1 2018 and 8 closed out, a net change of +1 holder.
- The largest Veracyte buyer in Q1 2018 was ARK Investment Management, an estimated $8.72M added.
- The largest Veracyte seller in Q1 2018 was Avoro Capital Advisors, an estimated $3.92M sold.
Based on aggregated 13F filings for Q1 2018.